Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
affective disorders
agitation
agranulocytosis
akathisia
akinetic mute
algorithm
alien hand syndrome
alpha-synuclein
Alzheimer's disease
amantadine
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinesterase
antidepressant
anxiety
aphasia
aphasia, progressive, primary
aphonia
applause sign
apraxia
apraxia of eyelid opening
aprazolam
aripiprazole
arm swing, reduced
ataxia
ataxia, cerebellar
ataxia, progressive
atypical
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autonomic cardiovascular reflexes
autonomic dysfunction
basal ganglia, infarction
basal ganglia, lesion, bilateral
behavioral disorder
benzodiazepine
bicycle sign
biologic markers
black box warning
blepharospasm
blinking
blinking, reduced
bradykinesia
bradykinesia, facial
bradyphrenia
burning mouth
burning paresthesia
burst suppression pattern, electroencephalogram
buspirone
cachexia
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortical atrophy
cerebral infarction, subcortical
cerebrovascular accident
cerebrovascular disease
chromosome 19
cingulate island sign
Clinical Pathologic Conference(C.P.C.)
clonazepam
clozapine
coat-hanger pain
cogentin
cognition
cogwheel rigidty
complications
compulsivity
cortical-basal ganglionic degeneration
cycling
degenerative diseases of CNS
delay in diagnosis
delirium
delusion
dementia
dementia, familial
dementia, frontotemporal
dementia, subcortical
deprenyl
depression
desipramine
diagnostic criteria
differential diagnosis
diplopia
dizziness
dopamine
dopamine agonist
dopamine antagonist
downward gaze
drug induced neurologic disorders
drug interactions
dyskinesia
dyskinesia, drug induced
dysphagia
dystonia
dystonia, drug induced
dystonia, face
dystonia, focal
dystonic reaction, acute
efficacy
electroconvulsive therapy
electron microscopy
emergencies, neurologic
emergency room
encephalitis, autoimmune
enzyme inhibition
epidemiology of neurology
erectile dysfunction
ergotamine
evidence-based research
extrapyramidal movement disorder, progressive
eye movement, disorders of
facial appearance, abnormal
facial expression abnormality
falling
familial
fever
fine motor function, impaired
fluoxetine
frontal behavioral spatial syndrome
gait disorder
gait, apraxic
gammaglobulin therapy, intravenous
gaze palsy
gaze palsy, supranuclear
gaze palsy, vertical
gene mutation
gene therapy
genetic neurologic disorders
genetic testing
glutamic acid decarboxylase, antibody
hallucination
haloperidol
hand weakness
hands, fisted
head injury
hemidystonia
hemiparesis
heralding manifestation
hummingbird sign
hyperreflexia
hypertension
hypophonia
hyposmia
hypotension, neurologic causes of
hypotension, systemic
hypothyroidism
iatrogenic neurologic disorders
ideomotor apraxia
imbalance
imbalance, postural
immunomodulation
inclusion bodies
inclusion bodies, eosinophilic cytoplasmic
intracranial hypotension
jealousy
L-dopa
L-dopa, controlled release
L-dopa, drug interactions with and side effects of
leg spasms, painful
leucine rich glioma inactivated 1 antibodies
leukemia, neurologic findings assoc.with
leukoencephalopathy
level of consciousness, decreased
Lewy body
Lewy body disease, diffuse
life expectancy
lorazepam
marche a petits pas
masked facies
memory, impairment of
meningitis
microangiopathy, brain
midbrain
midbrain, atrophy
mimics
Mini Mental Status Examination
misdiagnosis
morning glory sign
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
MRI, abnormal
MRI, negative
multiple sclerosis
multiple sclerosis, treatment of
multiple system atrophy
muscle cramp
muscle spasm
myelomeningocele
myoclonus
neck pain
neurofilament light chain protein
neurofilaments
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications
neurologic disease, diagnoses of
neurologic disease, tempo
neurologic signs
neurologic symptoms
neuroophthalmology
neuropathology
neuropathology, brain
nortriptyline
obsessive-compulsive disorder
olanzapine
old age, neurology of
ondansetron
ophthalmoplegia
ophthalmoplegia, total
orthostatic hypotension
Othello syndrome
pain
pain, genital
pain, mouth
pallidotomy
panic attacks
paranoia
Parkinson disease
Parkinson disease, akinetic form
Parkinson disease, arteriosclerotic
Parkinson disease, asymmetric onset
Parkinson disease, atypical
Parkinson disease, axial symptoms
Parkinson disease, benign tremulous
Parkinson disease, complications, late
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug induced
Parkinson disease, duration
Parkinson disease, dystonia with
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, exacerbation
Parkinson disease, familial
Parkinson disease, fluctuations in
Parkinson disease, heterogeneity of
Parkinson disease, intractable
Parkinson disease, L-dopa nonresponsive
Parkinson disease, misdiagnosis
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, rapid onset
Parkinson disease, rapid progression
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, transient
Parkinson disease, treatment of
Parkinson disease, tremor, absence of
Parkinson disease, unilateral
Parkinson disease, wearing off
Parkinson disease, young onset
Parkinsonism hyperpyrexia syndrome
Parkinsonism multiple-system atrophy
Parkinsonism syndrome
Parkinsonism, freezing phenomena in
Parkinsonism-dementia complex
patient information and support
penguin silhouette sign
personality change
phenothiazine
phenothiazine, dyskinesia associated with
postural abnormality
practice guidelines
preclinical
primary intracranial hypotension
prognosis
progressive neurologic disorder
progressive supranuclear palsy
pseudobulbar palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
psychotic behavior
pull test
pyramidal tract dysfunction
quetiapine
rapid onset dystonia parkinsonism
rapidly progressing neurologic illness
reading disorder, acquired
reading problem, causes of
Red flags
remote effect of cancer on the nervous system
retrocollis
review article
rigidity
rigidity, axial
risk factors
risperidone
Romberg's sign
saccadic eye movements
saccadic eye movements, abnormal
safety
sagging of the brain
salivation, excessive
seizure
selective serotonin reuptake inhibitors
sequencing difficulty
serotonin syndrome
shoulder, pain in
sinemet
single photon emission computed tomography
skin, biopsy
sleep pathology and physiology
small vessel disease
SNCA duplication
speech disorder
standing difficulty
stare
stereotaxic surgery
stiff man syndrome
stimulation, deep brain
swallow evaluation
syncope
synucleinopathy
systemic illness
tandem gait, ataxic
tardive dyskinesia
tau protein
tauopathy
temporal lobe, lesion
temporal lobe, lesion, bilateral
thalamotomy
trazodone
treatment of neurologic disorder
tremor
tremor, intention
tremor, resting
tremor, surgical treatment of
tremor, treatment of
tricyclic antidepressant
urinary incontinence
vision, blurred
visual symptoms
walking, difficulty with
weight loss
wheelchair
wide based gait
Showing articles 300 to 350 of 1482 << Previous Next >>

What Predicts Mortality in Parkinson Disease? A Prospective Population-Based Long-Term Study
Neurol 75:1270-1276, Forsaa,E.B.,et al, 2010

Traumatic Brain Injury - Football, Warfare, and Long-Term Effects
NEJM 363:1293-1296, DeKosky,S.T.,et al, 2010

The Spectrum of Mutations in Progranulin: A Collaborative Study Screening 545 Cases of Neurodegeneration
Arch Neurol 67:161-170,145, Yu,C.-E.,et al, 2010

Cycling for Freezing of Gait
NEJM 362:e46, Snijders,A.H., &Bloem,B.R., 2010

Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Arch Neurol 67:58-63, Rabinak,C. &Nirenberg,M., 2010

Practice Parameter: Treatment of Nonmotor Symptoms of Parkinson Disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 74:924-931, Zesiewicz,T.A.,et al, 2010

(-Synuclein Accumulation in Skin Nerve Fibers Revealed by Skin Biopsy in Pure Autonomic Failure
Neurol 74:608-610,536, Shishido,T.,et al, 2010

A Multidisciplinary Study of Patients with Early-Onset PD with and Without Parkin Mutations
Neurol 72:110-116,106, Lohmann,E.,et al, 2009

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients with Advanced Parkinson Disease: A Randomized Controlled Trial
JAMA 301:63-73,104, Weaver,F.M.,et al, 2009

Overweight After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Long Term Follow-Up
JNNP 80:484-488, Bannier,S.,et al, 2009

High-Resolution Diffusion Tensor Imaging in the Substantia Nigra of De Novo Parkinson Disease
Neurol 72:1378-1384,1374, Vaillancourt,D.E.,et al, 2009

Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol 66:563-570, Parkinson Sutdy Group CALM Cohort Investigators, 2009

Parkinsonism in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Neurol 73:401-403, Tisch,S. &Brew,B., 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

A 75-Year-Old Woman with Progressive Right-Hand Tremor and Inability to Use Her Right Side
Neurol 73:1399-1405, Kertesz,A.,et al, 2009

Family History of Melanoma and Parkinson Disease Risk
Neurol 73:1286-1291, Gao,X.,et al, 2009

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009

Road Safety in Drivers With Parkinson Disease
Neurol 73:2112-2119, Uc,E.,et al, 2009

Imaging-Pathologic Correlation in Corticobasal Degeneration
AJNR 30:1884-1892, Tokumaru,A.,et al, 2009

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

Posterior Reversible Encephalopathy Syndrome: Incidence of Atypical Regions of Involvement and Imaging Findings
AJR 189:904-912, McKinney, A.M.,et al, 2009

Aicardi-Gouti�res Syndrome
Br Med Bull 89:183-201, Orcesi, S.,et al, 2009

Bilateral Basal Ganglia Lesions in Patients with End-Stage Diabetic Nephropathy
Nephrology 13:68-72, Li, J.,et al, 2008

Diffusion-Weighted MR Imaging: Diagnosing Atypical or Malignant Meningiomas and Detecting Tumor Dedifferentiation
AJNR 29:1147-1152, Nagar,V.A., et al, 2008

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Levodopa for the Treatment of Parkinsons Disease
NEJM 359:2468-2476, LeWitt,P.A., 2008

Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008

Second Consensus Statement on the Diagnosis of Multiple System Atrophy
Neurol 71:670-676, Gilman,S.,et al., 2008

Attempted and Completed Suicides After Subthalamic Nucleus Stimulation for Parkinsons Disease
JNNP 79:952-954, Soulas,T.,et al., 2008

Superficial Siderosis: A Potential Diagnostic Marker of Cerebral Amyloid Angiopathy in Alzheimer Disease
Stroke 39:2894-2897,2699, Feldman,H.H.,et al, 2008

Exposure to Antipsychotics and Risk of Stroke: Self Controlled Case Series Study
BMJ 337:616-618,586, Douglas,I.J. &Smeeth,L., 2008

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008

Association of Olfactory Dysfunction With Risk for Future Parkinsons Disease
Ann Neurol 63:167-173,132, Ross,G.W.,et al, 2008

Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008

Invited Article: Nervous System Pathology in Sporadic Parkinson Disease
Neurol 70:1916-1925, Braak,H. & Del Tredici,K., 2008

Reversible Parkinsonism and Ataxia Associated With High-Dose Octreotide
Neurol 70:2345-2346, Espay,A.J., 2008

Serum Uric Acid and Clinical Progression in Parkinson Disease: Potential Biomarker for Nigrostriatal Failure
Arch Neurol 65:698-699, Schiess,M. &Oh,I., 2008

Fourteen-Year Final Report of the Randomized PDRG-UK Trial Comparing Three Treatments in PD
Neurol 71:474-480.470, Katzenschlager,R.,et al., 2008

Rhinorrhea and Olfaction in Parkinson Disease
Neurol 70:487-489, Friedman, J.H.,et al, 2008

Fragile X-Associated Tremor/Ataxia Syndrome: An Aging Face of the Fragile X Gene
Arch Neurol 65:19-25, Amiri,K.,et al, 2008

Increased Risk of Parkinsonism in Women Who Underwent Oophorectomy Before Menopause
Neurol 70:200-209, Rocca,W.A.,et al, 2008

Functional Imaging of the Cerebral Olfactory System in Patients with Parkinsons Disease
JNNP 79:19-24, Westermann,B.,et al, 2008

Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial
Lancet 371:57-63,9, Tyrer,P.,et al, 2008

a-Synuclein Gene Duplication Is Present in Sporadic Parkinson Disease
Neurol 70:43-49,7, Ahn,T.-B.,et al, 2008

A 23-Year-Old Man With Seizures and Visual Deficit
Neurol 70:73-78, Boustany,R.-M.,et al, 2008

Statin Use and the Risk of Parkinson Disease
Neurol 70:1418-1422, Wahner,A.D.,et al, 2008

Use of Antihypertensives and the Risk of Parkinson Disease
Neurol 70:1438-1444, Becker,C.,et al, 2008

Functional Imaging in Parkinson Disease
Neurol 70:1478-1488, Nandhagopal,R.,et al, 2008

Dementia and Survival in Parkinson Disease: A 12-Year Population Study
Neurol 70:1017-1022, Buter,T.C.,et al, 2008



Showing articles 300 to 350 of 1482 << Previous Next >>